PRCT PROCEPT BioRobotics Corp: institutional ownership and insider trading

276 funds reported holding $1.48B of PROCEPT BioRobotics Corp in their latest 13F filings; in Q2 2026 funds net sold $27.4M, with 35 new positions and 36 funds selling out; over the last 12 months insiders bought $11.0M and sold $624K on the open market; over its last four quarters it reported revenue of $337M and net income of −$14.3M.

PRCT revenue and earnings

Famous investors holding PRCT

Largest institutional holders of PRCT

  1. VANGUARD GROUP INC — $164M
  2. BlackRock, Inc. (BLK) — $110M
  3. T. Rowe Price Investment Management, Inc. — $73.7M
  4. BNP Paribas Asset Management Holding S.A. — $63.8M
  5. VANGUARD PORTFOLIO MANAGEMENT LLC — $57.1M
  6. VANGUARD CAPITAL MANAGEMENT LLC — $55.6M
  7. AXA Investment Managers S.A. — $39.6M
  8. STATE STREET CORP (STT, STT-PG) — $36.5M
  9. GEODE CAPITAL MANAGEMENT, LLC — $33.5M
  10. FMR LLC — $32.6M

Recent PRCT insider trades

5%+ owners

Who owns the most PRCT stock?

The largest institutional holders of PROCEPT BioRobotics Corp in the latest 13F filings are VANGUARD GROUP INC ($164M), BlackRock, Inc. (BLK) ($110M), T. Rowe Price Investment Management, Inc. ($73.7M).

Are insiders buying or selling PRCT?

Over the last 12 months insiders bought $11.0M and sold $624K of PROCEPT BioRobotics Corp stock on the open market (SEC Form 4).

Which famous investors own PRCT?

Izzy Englander, Ken Griffin, Two Sigma.

What was PRCT's revenue last quarter?

PROCEPT BioRobotics Corp reported revenue of $94.5M for the quarter ended June 30, 2026, with net income of −$26.9M.

Which ETFs hold PRCT?

24 ETFs and mutual funds hold it among their top 100 positions, including JANVX, QASCX, BOTZ, CIPNX.

All PRCT 13F holders · All PRCT insider trades